切换至 "中华医学电子期刊资源库"

中华移植杂志(电子版) ›› 2024, Vol. 18 ›› Issue (05) : 302 -309. doi: 10.3877/cma.j.issn.1674-3903.2024.05.009

荟萃分析

儿童肝移植受者健康相关生存质量评价的荟萃分析
刘冉佳1, 崔向丽1,(), 周效竹1,2, 曲伟3, 朱志军3   
  1. 1.100050 北京,首都医科大学附属北京友谊医院药剂科
    2.100069 北京,首都医科大学药学院
    3.100050 北京,首都医科大学附属北京友谊医院肝移植中心
  • 收稿日期:2023-10-20 出版日期:2024-10-25
  • 通信作者: 崔向丽
  • 基金资助:
    国家卫生健康委医院管理研究所医院药学高质量发展研究项目(NIHAYS2302)

A systematic review of health-related quality of life assessment for pediatric liver transplant recipients

Ranjia Liu1, Xiangli Cui1,(), Xiaozhu Zhou1,2, Wei Qu3, Zhijun Zhu3   

  1. 1.Department of Pharmacy, Capital Medical University,Beijing 100050, China
    2.School of Pharmacy, Capital Medical University, Beijing 100069, China
    3.Liver Transplantation Center, Beijing Friendship Hospital, Capital Medical University,Beijing 100050, China
  • Received:2023-10-20 Published:2024-10-25
  • Corresponding author: Xiangli Cui
引用本文:

刘冉佳, 崔向丽, 周效竹, 曲伟, 朱志军. 儿童肝移植受者健康相关生存质量评价的荟萃分析[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 302-309.

Ranjia Liu, Xiangli Cui, Xiaozhu Zhou, Wei Qu, Zhijun Zhu. A systematic review of health-related quality of life assessment for pediatric liver transplant recipients[J/OL]. Chinese Journal of Transplantation(Electronic Edition), 2024, 18(05): 302-309.

目的

对国内外儿童肝移植受者术后健康相关生存质量(HR-QOL)评估报告进行系统综述及荟萃分析,探索儿童肝移植受者HR-QOL的影响因素。

方法

系统检索2016年1月至2023年2月国内外医学专业数据库,纳入儿童肝移植受者HR-QOL评估相关研究。汇总儿童生存质量评估模型4.0通用核心量表(PedsQL4.0)和儿童生存质量评估模型3.0移植模块(PedsQL3.0TM)得分情况,总结HR-QOL影响因素,并进行荟萃分析,比较不同答卷人和不同量表的得分差异。纳入连续型变量,以标准均值差(SMD)为效应统计量,并给出点估计值和95%可信区间(CI)。

结果

共纳入19项研究,其中 15项研究使用PedsQL4.0,总分为55~88.1分;9项研究使用PedsQL3.0TM,总分为64.9~ 91分。疾病、疲劳和睡眠等因素是儿童肝移植受者HR-QOL的预测因子。荟萃分析结果显示,PedsQL4.0家长代填得分低于患儿自答得分(SMD=-0.18,95%CI:-0.31~-0.04,P<0.05),PedsQL3.0TM患儿自答与家长代填得分差异无统计学意义(SMD=0.03,95%CI:-0.15~0.20,P>0.05),PedsQL3.0TM得分高于PedsQL4.0得分(SMD=0.35,95%CI:0.18~0.53,P<0.05)。

结论

儿童肝移植受者生存质量评价存在数量少、质量差、异质性大等问题。儿童肝移植受者HR-QOL受多种因素影响,PedsQL4.0患儿自答评分与家长代填评分结果存在差异,使用PedsQL3.0TM量表可能获得更好的一致性。

Objective

To systematically review and meta-analyze the evaluation reports of health-related quality of life (HR-QOL) in pediatric liver transplant recipients at home and abroad,and to explore the influencing factors of HR-QOL in pediatric liver transplant recipients.

Methods

A systematic search of domestic and foreign medical professional databases from January 2016 to February 2023 was performed to include studies related to HR-QOL assessment in pediatric liver transplant recipients. To summarize the scores of the pediatric quality of life inventory 4.0 generic core scales(PedsQL4.0) and the pediatric quality of life inventory 3.0 transplant module (PedsQL3.0TM),summarize the influencing factors of HR-QOL, and perform a meta-analysis to compare the differences in scores between different respondents and different scales. Continuous variables were introduced and standardized mean difference (SMD) were used as effect statistics, and point estimates and 95%confidence intervals (CI) were given.

Results

A total of 19 studies were included. Fifteen studies used PedsQL4.0 with a total score of 55 to 88.1 points. Nine studies used PedsQL3.0TM with a total score of 64.9 to 91 points. Disease factors, fatigue, and sleep are identified as predictors for HR-QOL in pediatric liver transplant recipients. Meta-analysis results indicated that parent-reported scores using the PedsQL4.0 were significantly lower than child self-reports (SMD=-0.18, 95%CI:-0.31 to -0.04, P<0.05), there was no significant difference in scores between child self-reports and parent reports using the PedsQL3.0TM (SMD=0.03, 95%CI:-0.15 to 0.20, P>0.05), and the PedsQL 3.0TM scores were significantly higher than those obtained with the PedsQL 4.0 scale (SMD=0.35, 95%CI:0.18 to 0.53, P<0.05).

Conclusions

There are some problems in the quality of life evaluation of pediatric liver transplantation, such as small quantity, poor quality and heterogeneity. The HR-QOL of pediatric liver transplantation recipients is affected by many factors. here are differences between parent and child reports of PedsQL4.0. Better consistency can be obtained by using PedsQL3.0TM.

图1 文献纳入流程
表1 儿童肝移植受者术后HR-QOL评估相关研究的基本特征和质量评价结果
作者 发表年份 国家 纳入受者人数(例) 答卷时受者年龄[xˉ±s/MP25,P75)] 移植年龄[xˉ±s/MP25,P75)] 肝移植后时间[xˉ±s/MP25,P75)] 答卷人 HR-QOL测量工具 EPHPP评价结果
桂晓燕[9] 2022 中国 50 (88.6±7.2)月 - ≥1年 父母 Strong
Getsuwan[10] 2021 泰国 52 6.5(4.6,9.4)岁 1.6(1.2,2.5)岁 4.7(3.3,7.2)年 患儿+父母 Weak
Grant[11] 2021 加拿大 129 13.6(8,18)岁 2.5(1天,16.7岁) - 患儿+父母 ①②③ Moderate
Hind[12] 2021 加拿大 19 14.5(9.60,17.2)岁 1.4(0.8,3.0)岁 (11.3±4.8)年 患儿 ①② Weak
Lui[13] 2021 加拿大 15 12(11,17)岁 1.0(1.0,3.0)岁 121(85,170)月 患儿 ①② Weak
Mohammad[14] 2021 美国 88 11(8,13)岁 1(1,2)岁 9(6,11)年 患儿+父母 ①② Strong
Bharij[15] 2020 美国 108 (13.6±3.5)岁 (4.7±4.6)岁 (8.9±4.9)年 患儿+父母 ①②③ Weak
Ohnemus[16] 2020 美国 69 16.1(12.9,18.0)岁 1.1(0.1,4.8)岁 14.5(10.7,17.5)年 患儿+父母 Strong
Ünay[17] 2020 土耳其 20 (11.15±4.32)岁 (2.45±3.15)岁 0.17~5年 患儿+父母 Moderate
Bos[18] 2019 荷兰 26 9.7(7.7,11.4)岁 - ≥1年 患儿+父母 Strong
Joffe[19] 2019 加拿大 78 (55.4±7.2)月 - (38.6±12.4)月 父母 Strong
Miserachs[20] 2019 加拿大 70 8~12岁 8.9(7,11.9)月 8.9(7.9,10.2)年 患儿+父母 ②③ Strong
Petersen[21] 2019 德国 100 (12.0±4.5)岁 (2.5±3.2)岁 (9.5±4.6)年 患儿+父母 Strong
高峰[22] 2019 中国 64 (18.5±3.6)月 - - 父母 Weak
陆晔峰[23] 2019 中国 40 97.5(66,180)月 11(5,121)月 ≥5年 父母 Moderate
Kikuchi[24] 2018 日本 75 (9.6±3.7)岁 - (8.9±3.9)年 患儿+父母 ①② Moderate
杨旸[2] 2018 中国 53 4.2岁 - - 父母 Strong
Feldman[25] 2016 美国 260 5.9(2.6,13.1)岁 4.8(1.3,11.4)岁 ≥1年 患儿+父母 Moderate
Vandekerckhove[26] 2016 比利时 31 (11.6±2.9)岁 (3.3±3.1)岁 (8.2±3.7)年 患儿 Weak
表2 儿童肝移植受者术后HR-QOL评估相关研究的PedsQL4.0调查结果[/M(P25,P75),分]
作者 量表版本 实际报告人数(例) 总分 生理功能 情感功能 社交功能 角色功能
Grant[11] 儿童版 129 74.32±19.03 - - - -
家长版 129 70.78±18.45 - - - -
Hind[12] 儿童版 19 83(77,92) 94(83,100) 75(70,98) 95(85,100) 75(65,83)
Lui[13] 儿童版 15 65(55,88) 91(63,100) 65(45,90) 75(60,100) 62±24
Mohammad[14] 儿童版 82 80.7±13.7 86.1±13.9 79.6±18.4 82.2±19.9 71.4±18.7
家长版 87 79.2±15.0 83.6±18.5 75.6±19.6 83.2±16.5 71.0±19.8
Bharij[15] 儿童版 96 78.7±17.9 - - - -
家长版 91 76.5±21.3 - - - -
Ohnemus[16] 儿童版 60 78.6±15.9 83.6±17.0 75.4±21.9 84.6±17.6 67.8±21.6
家长版 65 77.5±16.3 84.7±19.0 71.6±22.0 82.9±19.8 66.4±22.0
Joffe[19] 家长版 69 75.6±15.6 78.2±20.9 73.8±16.4 74.6±19.2 70.6±19.1
Ünay[17] 儿童版 20 67.01±17.48 59.37±27.13 - - -
家长版 20 56.3±17.01 49.38±24.18 - - -
Bos[18] 儿童版 25 75.0(64.1,80.4) 81.3(67.2,92.2) 65.0(57.5,82.5) 80.0(65.0,92.5) 70.0(50.0,72.5)
家长版 26 71.2(57.6,84.2) 84.4(58.6,91.4) 66.9(50.0,80.0) 70.0(63.8,90.0) 65.0(48.8,75.0)
Petersen[21] 儿童版 71 80.97±13.42 84.39±15.39 79.39±17.74 87.48±18.38 73.29±15.10
家长版 100 74.91±18.52 78.41±21.38 77.67±21.11 79.15±22.39 64.20±22.46
Miserachs[20] 儿童版 69 77.17(65.9,85.86) - - - -
家长版 68 79.13(64.13,87.22) - - - -
Kikuchi[24] 儿童版 75 88.1±12.1 91.6±15.0 87.2±17.3 91.4±13.7 80.8±19.1
家长版 74 80.2±16.0 86.0±19.6 79.5±17.7 81.2±18.6 70.4±21.4
杨旸[2] 家长版 53 - 73.88±16.33 62.17±17.61 71.51±25.82 63.30±21.17
Feldman[25] 儿童版 98 77.6±16.1 81.2±17.3 - - -
家长版 261 75.8±17.9 77.1±23.7 - - -
Vandekerckhove[26] 儿童版 31 77.6±11 83.3±13.4 76.5±18.7 79.8±17.7 70.9±14.7
表3 儿童肝移植受者术后HR-QOL评估相关研究的PedsQL3.0TM调查结果[/M(P25,P75),分]
作者 量表版本 实际报告人数(例) 总分 药物依从性 药物不良反应 移植后社会关系 疼痛和伤害 担忧 对治疗的焦虑 对外貌的自我感觉 交流
桂晓燕[9] 家长版a
胆道闭锁 25 72.7±14.9 82.4±13.2 77.8±17.4 72.0±15.9 73.7±18.7 55.7±12.8 66.8±14.1 67.0±11.2 80.8±16.3
丙酸血症 25 64.9±8.7 71.7±7.9 67.8±10.9 70.5±14.5 72.6±14.5 56.9±10.1 65.2±12.6 64.2±13.1 77.0±14.2
Grant[11] 儿童版 129 80.50±14.28 - - - - - - - -
家长版 129 79.44±14.22 - - - - - - - -
Hind[12] 儿童版 19 91(87,97) 94(93,97) 100(97,100) 88(80,97) 75(58,96) 93(86,100) 100(91,100) 92(71,100) 94(88,100)
Lui[13] 儿童版 15 77(66,93) 86(69,94) 94(86,100) 69(53,97) 67(58,83) 79(61,89) 75(44,94) 92(58,100) 75(50,100)
Getsuwan[10] 儿童版 37 80(70,88) 89(78,100) 89(81,100) 70(54,88) 83(53,100) 88(59,100) 88(63,100) 67(42,90) 75(50,100)
家长版 52 77(71,88) 89(72,94) 88(78,96) 77(63,84) 75(67,92) 71(58,86) 81(70,94) 83(67,100) 75(63,100)
Bharij[15] 儿童版 94 82.8±12.8 - - - - - - - -
家长版 91 85.3±12.7 - - - - - - - -
高峰[22] 家长版 64 68.37±13.90 76.74±17.26 77.90±16.41 65.92±20.06 79.43±13.52 54.07±25.59 49.32±25.37 58.85±28.09 84.67±15.86
陆晔峰[23] 家长版 40 73.2±13.8 84.1±11.6 77.7±15.3 69.9±17.3 72.9±19.6 57.7±25.4 69.8±24.1 69.8±24.1 79.9±19.5
Kikuchi[24] 儿童版 75 86.0±11.0 86.1±13.8 94.3±12.2 84.0±17.9 90.3±16.2 89.7±14.0 87.3±18.9 69.6±28.7 74.4±25.5
家长版 74 75.8±12.3 87.2±13.2 87.9±14.2 68.4±18.3 88.0±17.1 55.7±21.1 75.3±18.5 63.3±23.8 76.7±17.5
图2 儿童肝移植受者术后家长与患儿作答PedsQL4.0得分的荟萃分析结果及森林图 注:PedsQL4.0. 儿童生存质量评估模型4.0通用核心量表
图3 儿童肝移植受者术后家长与患儿作答PedsQL3.0TM得分的荟萃分析结果及森林图 注:PedsQL3.0TM. 儿童生存质量评估模型3.0移植模块
图4 儿童肝移植受者术后PedsQL4.0与PedsQL3.0TM得分的荟萃分析结果及森林图 注:PedsQL4.0. 儿童生存质量评估模型4.0通用核心量表; PedsQL3.0TM. 儿童生存质量评估模型3.0移植模块
1
张洪涛, 李霄, 陶开山. 中国肝移植免疫抑制治疗与排斥反应诊疗规范(2019版)[J/CD]. 中华移植杂志:电子版, 2019,13(4):262-268.
2
杨旸, 辛文琼, 向波, 等. 儿童活体肝移植受体术后的生活质量及其影响因素[J]. 中国普外基础与临床杂志, 2018,25(8):912-916.
3
Gutierrez Colina AM, Quast LF, Eaton CK, et al. Sleep quality is associated with psychosocial functioning and health-related quality of life in pediatric transplant recipients[J]. Pediatr Transplant, 2019,23(8):e13577.
4
刘冉佳, 张志琪, 黄文华, 等. 肝移植儿童生命质量评估量表的系统综述[J]. 药物流行病学杂志, 2022,31(4):264-270.
5
Parmar A, Vandriel SM, Ng VL. Health-related quality of life after pediatric liver transplantation:A systematic review[J]. Liver Transpl, 2017,23(3):361-374.
6
Thomas BH, Ciliska D, Dobbins M, et al. A process for systematically reviewing the literature:providing the research evidence for public health nursing interventions[J]. Worldviews Evid Based Nurs,2004,1(3):176-184.
7
Wan X, Wang W, Liu J, et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range[J]. BMC Med Res Methodol, 2014,14:135.
8
Luo D, Wan X, Liu J, et al. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range[J]. Stat Methods Med Res, 2018,27(6):1785-1805.
9
桂晓燕, 陆晔峰. 先天性胆管闭锁及丙酸血症患儿肝移植术后生活质量的比较研究[J]. 全科护理, 2022,20(29):4150-4152.
10
Getsuwan S, Tanpowpong P, Lertudomphonwanit C, et al. Healthrelated quality of life in pediatric liver transplant recipients[J].Transplant Proc, 2021,53(1):141-147.
11
Grant A, Ng VL, Nicholas D, et al. The effects of child anxiety and depression on concordance between parent-proxy and self-reported health-related quality of life for pediatric liver transplant patients[J].Pediatr Transplant, 2021,25(7):e14072.
12
Hind T, Lui S, Moon E, et al. Post-traumatic stress as a determinant of quality of life in pediatric solid-organ transplant recipients[J]. Pediatr Transplant, 2021,25(4):e14005.
13
Lui S, Hind T, Moon E, et al. Self-reported physical activity and lack of association with health-related quality of life in a pediatric solid-organ transplant population[J]. Pediatr Transplant, 2021,25(8):e14093.
14
Mohammad S, Sundaram SS, Mason K, et al. Improvements in disease-specific health-related quality of life of pediatric liver transplant recipients during immunosuppression withdrawal[J]. Liver Transpl, 2021,27(5):735-746.
15
Bharij A, Neighbors K, Alonso EM, et al. Health utility and quality of life in pediatric liver transplant recipients[J]. Pediatr Transplant,2020,24(4):e13720.
16
Ohnemus D, Neighbors K, Rychlik K, et al. Health-related quality of life and cognitive functioning in pediatric liver transplant recipients[J]. Liver Transpl, 2020,26(1):45-56.
17
Ünay M, Önder A, Gizli Çoban Ö, et al. Psychopathology, quality of life, and related factors in pediatric liver transplantation candidates and recipients[J]. Pediatr Transplant, 2020,24(1):e13633.
18
Bos GJFJ, Lelieveld OTHM, Scheenstra R, et al. Physical activity and aerobic fitness in children after liver transplantation[J]. Pediatr Transplant, 2019,23(5):e13465.
19
Joffe AR, Wong K, Bond GY, et al. Kindergarten-age neurocognitive,functional, and quality-of-life outcomes after liver transplantation at under 6 years of age[J]. Pediatr Transplant, 2019,24(2):e13624.
20
Miserachs M, Parmar A, Bakula A, et al. Health-related quality of life in pre-adolescent liver transplant recipients with biliary atresia:a cross-sectional study[J]. Clin Res Hepatol Gastroenterol, 2019,43(4):427-435.
21
Petersen I, Noelle J, Buchholz A, et al. Fatigue in pediatric liver transplant recipients and its impact on their quality of life[J]. Pediatr Transplant, 2019,23(1):e13331.
22
高峰, 陆晔峰. 儿童肝移植术后一年生命质量及其影响因素研究[J]. 中国实用护理杂志, 2019,35(16):1256-1260.
23
陆晔峰, 王艳, 万平, 等. 肝移植患儿术后5年生活质量的调查[J]. 中国临床新医学, 2019,12(10):1057-1060.
24
Kikuchi R, Mizuta K, Urahashi T, et al. Quality of life after living donor liver transplant for biliary atresia in Japan[J]. Pediatr Int,2018,60(2):183-190.
25
Feldman AG, Neighbors K, Mukherjee S, et al. Impaired physical function following pediatric LT[J]. Liver Transplant, 2016,22(4):495-504.
26
Vandekerckhove K, Coomans I, De Bruyne E, et al. Evaluation of exercise performance, cardiac function, and quality of life in children after liver transplantation[J]. Transplantation, 2016,100(7):1525-1531.
27
中国肝移植注册中心, 国家肝脏移植医疗质量控制中心. 2019-2021年国家医疗服务与质量安全报告-肝脏移植专业分册[R].
28
夏强, 封明轩. 中国儿童肝移植的现状与挑战[J]. 中华消化外科杂志, 2024, 23(1):49-54.
29
Weissberg-Benchell J, Zielinski TE, Rodgers S, et al. Pediatric health-related quality of life:feasibility, reliability and validity of the PedsQL transplant module[J]. Am J Transplant, 2010,10(7):1677-1685.
30
Hager A, Mager D, Robert C, et al. Health-related quality of life 10 years after liver transplantation:a longitudinal retrospective review[J].Diagnostics, 2021,11(1):111.
31
赵红福, 徐宏宇, 杨红梅, 等. 儿童肝移植术后监护人疲劳状况、治疗依从性和患儿生存质量的相关性[J]. 当代护士(中旬刊), 2022,29(3):84-88.
[1] 陶宏宇, 叶菁菁, 俞劲, 杨秀珍, 钱晶晶, 徐彬, 徐玮泽, 舒强. 右心声学造影在儿童右向左分流相关疾病中的评估价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 959-965.
[2] 刘琴, 刘瀚旻, 谢亮. 基质金属蛋白酶在儿童哮喘发生机制中作用的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 564-568.
[3] 向韵, 卢游, 杨凡. 全氟及多氟烷基化合物暴露与儿童肥胖症相关性研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 569-574.
[4] 胡宁宁, 赵延荣, 王栋, 王胜亮, 郭源. FMNL3与肝细胞癌肝移植受者预后的相关性研究[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 283-288.
[5] 仲福顺, 余露, 范晓礼, 叶啟发. 肝移植治疗肝上皮样血管内皮瘤一例[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 293-297.
[6] 贺健, 张骊, 王洪海, 蒋文涛. 肝移植术后脾功能亢进转归及治疗研究进展[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 310-314.
[7] 丁荷蓓, 王珣, 陈为国. 七氟烷吸入麻醉与异丙酚静脉麻醉在儿童腹股沟斜疝手术中的应用比较[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 570-574.
[8] 傅斌生, 冯啸, 杨卿, 曾凯宁, 姚嘉, 唐晖, 刘剑戎, 魏绪霞, 易慧敏, 易述红, 陈规划, 杨扬. 脂肪变性供肝在成人劈离式肝移植中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 789-794.
[9] 魏志鸿, 刘建勇, 吴小雅, 杨芳, 吕立志, 江艺, 蔡秋程. 肝移植术后急性移植物抗宿主病的诊治(附四例报告)[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 846-851.
[10] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[11] 中华医学会器官移植学分会, 中华医学会外科学分会外科手术学学组, 中华医学会外科学分会移植学组, 华南劈离式肝移植联盟. 劈离式供肝儿童肝移植中国临床操作指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 593-601.
[12] 刘军, 丘文静, 孙方昊, 李松盈, 易述红, 傅斌生, 杨扬, 罗慧. 在体与离体劈离式肝移植在儿童肝移植中的应用比较[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 688-693.
[13] 张琛, 秦鸣, 董娟, 陈玉龙. 超声检查对儿童肠扭转缺血性改变的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 565-568.
[14] 陈晓胜, 何佳, 刘方, 吴蕊, 杨海涛, 樊晓寒. 直立倾斜试验诱发31 秒心脏停搏的植入心脏起搏器儿童一例并文献复习[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 488-494.
[15] 曹亚丽, 高雨萌, 张英谦, 李博, 杜军保, 金红芳. 儿童坐位不耐受的临床进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 510-515.
阅读次数
全文


摘要